Processa Pharmaceuticals Inc (PCSA)

Apr 24, 2025

Processa Pharmaceuticals Inc [PCSA] Shares Rise 8.43 % on Wednesday - knoxdaily.com

Apr 24, 2025

Apr 24, 2025

Processa Pharmaceuticals stock hits 52-week low at $0.65 - MSN

Apr 24, 2025

Apr 22, 2025

Processa Pharmaceuticals Inc (PCSA) can make a big difference with a little luck - Sete News

Apr 22, 2025

Apr 21, 2025

A Closer Look at Processa Pharmaceuticals Inc (PCSA) Stock Gains - investchronicle.com

Apr 21, 2025

Apr 21, 2025

Recent Insider Activity Suggests Potential Gains for Processa Pharmaceuticals Inc (PCSA) - knoxdaily.com

Apr 21, 2025

Apr 15, 2025

Processa Pharmaceuticals’ Dr. David Young to Present at World Orphan Drug Congress USA 2025 - GlobeNewswire

Apr 15, 2025

Apr 15, 2025

FDA Project Optimus: Processa Unveils New Approach for Rare Disease Treatment Success - Stock Titan

Apr 15, 2025

Apr 12, 2025

Data-Based Insights About Processa Pharmaceuticals Inc (PCSA) - stocksregister.com

Apr 12, 2025

Apr 11, 2025

Processa Pharmaceuticals stock hits 52-week low at $0.22 - Investing.com

Apr 11, 2025

Apr 10, 2025

PCSA Stock Sees Decline of Approximately -11.67% in Last Five Days - knoxdaily.com

Apr 10, 2025

Apr 02, 2025

Processa Pharmaceuticals stock hits 52-week low at $0.36 - Investing.com

Apr 02, 2025

Apr 02, 2025

Processa Pharmaceuticals stock hits 52-week low at $0.36 By Investing.com - Investing.com India

Apr 02, 2025

Mar 28, 2025

Processa Pharmaceuticals (PCSA) to Release Quarterly Earnings on Friday - Defense World

Mar 28, 2025

Mar 25, 2025

Processa Pharmaceuticals stock hits 52-week low at $0.4 By Investing.com - Investing.com South Africa

Mar 25, 2025

Mar 25, 2025

Processa Pharmaceuticals stock hits 52-week low at $0.4 - Investing.com

Mar 25, 2025

Mar 20, 2025

Processa Pharmaceuticals, Inc. SEC 10-K Report - TradingView

Mar 20, 2025

Mar 20, 2025

Processa Pharmaceuticals (PCSA) to Release Quarterly Earnings on Thursday - Defense World

Mar 20, 2025

Mar 20, 2025

Processa Pharmaceuticals Inc. (PCSA) reports earnings - qz.com

Mar 20, 2025

Mar 18, 2025

Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference - The Manila Times

Mar 18, 2025

Mar 18, 2025

Cancer Therapy Innovator Processa Pharmaceuticals Opens Door to Investors at Elite MedInvest Conference - StockTitan

Mar 18, 2025

Mar 13, 2025

Processa Pharmaceuticals stock hits 52-week low at $0.43 By Investing.com - Investing.com Australia

Mar 13, 2025

Mar 13, 2025

Processa Pharmaceuticals stock hits 52-week low at $0.43 - Investing.com India

Mar 13, 2025

Mar 11, 2025

Ulcerated Necrobiosis Lipoidica Market to Expand Significantly by 2034, States DelveInsight Reports | Processa Pharmaceuticals - Barchart

Mar 11, 2025

Mar 04, 2025

Processa Pharmaceuticals stock hits 52-week low at $0.46 - Investing.com

Mar 04, 2025

Feb 28, 2025

Processa Pharma Stock Price, Quotes and Forecasts - Benzinga

Feb 28, 2025

Feb 21, 2025

The Insider Secrets to Processa Pharmaceuticals: A Dark Horse in the Race - Elblog.pl

Feb 21, 2025

Feb 21, 2025

Hidden Gems: Why Insiders Are Banking on Processa Pharmaceuticals - Bit Perfect Solutions

Feb 21, 2025

Feb 21, 2025

Processa Pharmaceuticals, Inc. (PCSA): Among the Cheapest Stocks Insiders Are Buying Recently - Insider Monkey

Feb 21, 2025

Feb 20, 2025

10 Cheapest Stocks Insiders Are Buying Recently - Insider Monkey

Feb 20, 2025

Feb 13, 2025

Processa Pharmaceuticals faces Nasdaq delisting risk over share price By Investing.com - Investing.com Nigeria

Feb 13, 2025

Feb 11, 2025

Processa Pharmaceuticals (NASDAQ:PCSA) Publishes Investor Presentation - Defense World

Feb 11, 2025

Feb 10, 2025

Processa Pharmaceuticals faces Nasdaq delisting risk over share price - Investing.com

Feb 10, 2025

Feb 10, 2025

Processa Pharmaceuticals IncOn Feb 4, Received Nasdaq Notice For Bid Price Non-Compliance - Marketscreener.com

Feb 10, 2025

Feb 10, 2025

Processa Pharmaceuticals Inc (PCSA) Shares Soar Above 1-Year High - The News Heater

Feb 10, 2025

Feb 07, 2025

Processa Pharmaceuticals to Present at 2025 BIO CEO & Investor Conference - Nasdaq

Feb 07, 2025

Feb 07, 2025

Processa Pharmaceuticals to Present at the 2025 BIO CEO & Investor Conference - GlobeNewswire

Feb 07, 2025

Feb 07, 2025

Processa Pharma's Cancer Pipeline Takes Center Stage at Elite BIO Investor Conference - StockTitan

Feb 07, 2025

Feb 06, 2025

Gastroparesis Market Expected to rise, 2034 | Vanda - openPR

Feb 06, 2025

Feb 03, 2025

Financial Analysis: Processa Pharmaceuticals Inc (PCSA)’s Ratios Unveil Key Insights - The Dwinnex

Feb 03, 2025

Jan 31, 2025

Processa Pharmaceuticals CEO George Ng buys shares worth $69,542 - MSN

Jan 31, 2025

Jan 31, 2025

Processa Pharmaceuticals Announces Closing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules - GlobeNewswire

Jan 31, 2025

Jan 30, 2025

Processa Pharmaceuticals Raises $5M in Public Offering - TipRanks

Jan 30, 2025

Jan 30, 2025

Processa CEO Doubles Down: Purchases Shares at 30% Premium in $5M Strategic Raise - StockTitan

Jan 30, 2025

Jan 30, 2025

Processa Pharmaceuticals director David Young buys $99,288 in stock - Investing.com India

Jan 30, 2025

Jan 30, 2025

Processa Pharmaceuticals' chief business officer buys $34,691 in stock - MSN

Jan 30, 2025

Jan 30, 2025

12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga

Jan 30, 2025